Monsanto Co New (MON) Holder Cqs Cayman LP Has Raised Its Holding

July 14, 2018 - By Nadine Davis

Monsanto Company (NYSE:MON) LogoInvestors sentiment decreased to 0.75 in Q1 2018. Its down 0.06, from 0.81 in 2017Q4. It is negative, as 70 investors sold MON shares while 339 reduced holdings. 72 funds opened positions while 233 raised stakes. 311.73 million shares or 1.80% less from 317.44 million shares in 2017Q4 were reported. Inv House Ltd Company holds 10,456 shares or 0.15% of its portfolio. Toronto Dominion Retail Bank holds 1.33M shares or 0.35% of its portfolio. Ally Fincl invested in 25,000 shares. Perigon Wealth Mgmt Limited Com reported 188 shares. Highland Ltd Limited Liability Company accumulated 6,444 shares. Fdx Advisors Inc reported 12,672 shares. Gofen & Glossberg Ltd Liability Com Il stated it has 52,691 shares. Amp Cap Investors reported 185,373 shares. Tiaa Cref Invest Mngmt Ltd Liability Co accumulated 1.48 million shares. Great West Life Assurance Can accumulated 703,430 shares or 0.2% of the stock. Manikay Partners Ltd accumulated 1.67M shares. Stifel invested in 308,959 shares or 0.11% of the stock. Fisher Asset Mgmt Ltd Com has invested 0% in Monsanto Company (NYSE:MON). Moreover, Farmers State Bank has 0.1% invested in Monsanto Company (NYSE:MON). Wetherby Asset Management has invested 0.12% of its portfolio in Monsanto Company (NYSE:MON).

Michael Hintze increased its stake in Monsanto Co New (MON) by 432.02% based on its latest 2018Q1 regulatory filing with the SEC. Cqs Cayman Lp bought 715,000 shares as the company’s stock rose 2.93% while stock markets declined. The hedge fund run by Michael Hintze held 880,500 shares of the agricultural chemicals company at the end of 2018Q1, valued at $102.75M, up from 165,500 at the end of the previous reported quarter. Cqs Cayman Lp who had been investing in Monsanto Co New for a number of months, seems to be bullish on the $56.46B market cap company. The stock increased 0.02% or $0.02 during the last trading session, reaching $127.95. About 7.06M shares traded or 69.45% up from the average. Monsanto Company (NYSE:MON) has risen 8.56% since July 14, 2017 and is uptrending. It has underperformed by 4.01% the S&P500.

Cqs Cayman Lp, which manages about $2.17 billion US Long portfolio, decreased its stake in Biomarin Pharmaceutical Inc (Prn) by 6.00M shares to 26.00M shares, valued at $26.84M in 2018Q1, according to the filing. It also reduced its holding in Bhp Billiton Ltd (NYSE:BHP) by 493,650 shares in the quarter, leaving it with 248,514 shares, and cut its stake in Palo Alto Networks Inc (Prn).

Monsanto Company (NYSE:MON) Ratings Coverage

Among 3 analysts covering Monsanto (NYSE:MON), 0 have Buy rating, 1 Sell and 2 Hold. Therefore 0 are positive. Monsanto has $128.0 highest and $12800 lowest target. $128’s average target is 0.04% above currents $127.95 stock price. Monsanto had 3 analyst reports since January 17, 2018 according to SRatingsIntel. On Monday, April 9 the stock rating was downgraded by BMO Capital Markets to “Hold”. The stock has “Sell” rating by Argus Research on Monday, April 16. The firm earned “Hold” rating on Wednesday, January 17 by Wells Fargo.

Monsanto Company (NYSE:MON) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: